About RejuvenAir
RejuvenAir is a company based in Lexington (United States) founded in 2006. RejuvenAir has raised $171.11 million across 14 funding rounds from investors including Horizon Tech Finance, SV Health Investors and Ascension Ventures. RejuvenAir offers products and services including RejuvenAir System and SPRAY-CB Clinical Trial. RejuvenAir operates in a competitive market with competitors including Nuvaira, Asthmatx and D R Burton, among others.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Csa Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$171.11 M (USD)
in 14 rounds
-
Latest Funding Round
$59.66 M (USD), Series F
Aug 30, 2024
-
Investors
Horizon Tech Finance
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RejuvenAir
RejuvenAir offers a comprehensive portfolio of products and services, including RejuvenAir System and SPRAY-CB Clinical Trial.
Applies liquid nitrogen to treat Chronic Bronchitis airways.
Evaluates cryotherapy for reducing COPD symptoms.
People of RejuvenAir
Unlock access to complete
Funding Insights of RejuvenAir
RejuvenAir has successfully raised a total of $171.11M across 14 strategic funding rounds. The most recent funding activity was a Series F round of $59.66 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RejuvenAir
RejuvenAir has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizon Tech Finance, SV Health Investors and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for RejuvenAir
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RejuvenAir
Investment portfolio details for RejuvenAir
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RejuvenAir
Detailed financials for RejuvenAir
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rejuvenair Comparisons
Peer comparison for RejuvenAir
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RejuvenAir
RejuvenAir operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuvaira, Asthmatx and D R Burton, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A catheter-based system for COPD treatment is developed and provided.
|
|
| Locked | Locked | Locked |
Bronchial thermoplasty devices are developed for adult asthma treatment.
|
|
| Locked | Locked | Locked |
Provides comprehensive products for positive pressure therapy in lung disease patients.
|
Detailed competitors of RejuvenAir
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rejuvenair
Complete news archive for RejuvenAir
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RejuvenAir
RejuvenAir was founded in 2006 and raised its 1st funding round 1 year after it was founded.
RejuvenAir is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
RejuvenAir is a funded company, having raised a total of $171.11M across 14 funding rounds to date.
RejuvenAir was founded in 2006 and is located in Lexington, United States. A cryosurgical system targeting chronic bronchitis and COPD is developed within the medical device sector. Metered doses of cryogen spray are delivered via software-controlled dosimetry and specialized catheters to flash freeze damaged airway surfaces. Mucous production, cough, and inflammation are thereby reduced in affected patients. Operations focus on respiratory therapy innovations for clinical applications.
RejuvenAir's top competitors include Nuvaira, Asthmatx and D R Burton.
RejuvenAir offers RejuvenAir System and SPRAY-CB Clinical Trial.
RejuvenAir has 9 investors. Key investors include Horizon Tech Finance, SV Health Investors, Ascension Ventures, Intersouth Partners, and Blue Heron Capital.